EPIBAL Hard capsule Ref.[51161] Active ingredients: Pregabalin

Source: Υπουργείο Υγείας (CY)  Revision Year: 2022  Publisher: Delorbis Pharmaceuticals Ltd., 17 Athinon Street, Ergates Industrial Area, 2643 Ergates, P.O. Box 28629, 2081 Lefkosia, Cyprus, European Union

Product name and form

Epibal 25 mg hard capsules.

Epibal 50 mg hard capsules.

Epibal 75 mg hard capsules.

Epibal 150 mg hard capsules.

Pharmaceutical Form

Hard capsules.

Epibal 25 mg hard capsules: Hard capsules, size 4, with a white cap and a white body, with “25” printed in black ink on the body. The capsules contain a white to off-white powder.

Epibal 50 mg hard capsules: Hard capsules, size 3, with a white cap and a pinkish-orange body, with “50” printed in black ink on the body. The capsules contain a white to off-white powder.

Epibal 75 mg hard capsules: Hard capsules, size 4, with a brownish-red cap and a white body, with “75” printed in black ink on the body. The capsules contain a white to off-white powder.

Epibal 150 mg hard capsules: Hard capsules, size 2, with a white cap and a white body, with “150” printed in black ink on the body. The capsules contain a white to off-white powder.

Qualitative and quantitative composition

Epibal 25 mg hard capsules: Each hard capsule contains 25 mg of pregabalin.

Epibal 50 mg hard capsules: Each hard capsule contains 50 mg of pregabalin.

Epibal 75 mg hard capsules: Each hard capsule contains 75 mg of pregabalin.

Epibal 150 mg hard capsules: Each hard capsule contains 150 mg of pregabalin.

Excipients with known effect:

Epibal 25 mg hard capsules: Each hard capsule also contains 35 mg lactose monohydrate.

Epibal 50 mg hard capsules: Each hard capsule also contains 70 mg lactose monohydrate.

Epibal 75 mg hard capsules: Each hard capsule also contains 8.25 mg lactose monohydrate.

Epibal 150 mg hard capsules: Each hard capsule also contains 16.50 mg lactose monohydrate.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Pregabalin

Pregabalin binds to an auxiliary subunit (α2-δ protein) of voltage-gated calcium channels in the central nervous system.

List of Excipients

Capsule content:

Maize starch
Lactose monohydrate
Talc (E553b)

Capsule shell:

Titanium dioxide (E171)
Gelatin
Red iron oxide (E172) (for 50 mg and 75 mg)
Yellow iron oxide (E172) (for 50 mg)

Printing ink:

Black iron oxide
Shellac
Propylene glycol
Potassium hydroxide

Pack sizes and marketing

PVC/Aluminium blisters containing 14, 21, 56, 70 (only for 75 mg), 84 or 100 hard capsules.

Not all pack sizes may be marketed.

Marketing authorization holder

Delorbis Pharmaceuticals Ltd., 17 Athinon Street, Ergates Industrial Area, 2643 Ergates, P.O. Box 28629, 2081 Lefkosia, Cyprus, European Union

Marketing authorization dates and numbers

M.L.: 022805 (25MG)
M.L.: 022806 (50MG)
M.L.: 022807 (75MG)
M.L.: 022808 (150MG)

Date of first authorisation: 25 May 2018 / 03/10/2022

Drugs

Drug Countries
EPIBAL Cyprus, Malta

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.